<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04124133</url>
  </required_header>
  <id_info>
    <org_study_id>CHILD study</org_study_id>
    <nct_id>NCT04124133</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy and Safety of Ialuset Cream and Gauze in Second-degree Burns on Child</brief_title>
  <official_title>Observational Retrospective Study Evaluating Efficacy and Safety of Ialuset Cream or Gauzepad in Second Degree Burns Use for Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Genévrier</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Genévrier</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational retrospective monocentric study occured in the univeristy hospital center of
      Bensançon the department of pediatric surgery.

      Data of patients treated in the hospital between January 2016 and January 2019 have been
      collected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coordinator investigator have put in place a protocol care for children with second degree
      burns since 2016.

      It consists in detersion and cleaning of wound, application of ialuset cream and gauzepad
      (hyaluronic acid) during 21 days. After 21 days if patients are not healed, physician
      consider to perform grafting
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2018</start_date>
  <completion_date type="Actual">April 18, 2019</completion_date>
  <primary_completion_date type="Actual">April 18, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient rate with complete healing</measure>
    <time_frame>21 days</time_frame>
    <description>pourcentage of patient with 100% of reepithelilisation</description>
  </primary_outcome>
  <enrollment type="Actual">92</enrollment>
  <condition>Second-degree Burn of Children</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dressing with hyaluronic acid</intervention_name>
    <description>Application of ialuset cream or gauzepad (hyaluronic acid)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children from 1month to 15 years with a second degree burn
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  second-degree burns

          -  less than 20% of the body surface

          -  less than 15 years old

          -  treated within 24 hours

          -  1st line of treatment with ialuset

          -  treated at the center between 2016 and 2019

        Exclusion Criteria:

          -  patient who refused data collection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>15 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Fotso Kamdem</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 10, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2019</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

